Funded Research

Our research efforts center on understanding individual- and community-level factors that influence health behavior choices and developing ways to encourage positive behavior change.

In the last decade, the HIV prevention field has witnessed a distinct shift, with emphasis on biomedical strategies to supplement behavioral interventions. One of these approaches is the use of preexposure prophylaxis (PrEP), co-formulated antiretroviral medications taken to reduce the risk of HIV infection.
This study will develop and initially test an intervention designed to help young adults who regularly use marijuana to reduce their intake.
The Global Adult Tobacco Survey (GATS) was created by major national and international health agencies to improve the ability of countries to design, implement and evaluate anti-tobacco efforts.
This study will explore social and behavioral determinants of HIV testing and uptake of pre-exposure prophylaxis (PrEP) among young men who have sex with men in Western New York.
Sleep disturbances are cardinal features of veterans with post-traumatic stress disorder. This randomized cross-over trial will examine two treatment options for sleep apnea among veterans.
Operation: SAFETY is a longitudinal research study which will examine the health and well-being of U.S. Army Reserve/National Guard Soldiers and their partners.
Despite the commonly held belief that marijuana suppresses aggression, many cross-sectional and longitudinal surveys find positive associations between marijuana use and intimate partner violence (IPV).
The prevention of HIV acquisition has been transformed over the last decade with the introduction of pre-exposure prophylaxis (PrEP), in which at-risk HIV uninfected individuals take antiretroviral medications daily to prevent infection. 
This study aims to shed light on these poorly understood and critically important questions as part of a concerted strategy to improve SUD outcomes and decrease HIV infections.
To maximize its prevention potential, the public health impact of pre-exposure prophylaxis (PrEP) requires an approach that will lead to: 1) large-scale adoption among eligible populations and 2) identification of current gaps among prescribers.